 Source: Shutterstock PopTika Virios Therapeutics NASDAQ: VIRI stock is falling hard on Monday after the company revealed results from its Phase 2b Study of IMC-1 in Fibromyalgia. IMC-1 is a treatment in development by the company for people suffering from Fibromyalgia. 